Innovative R&D: Advancing Oncology and Skeletal Disease Models
Pharmatest offers efficacy models for oncology and skeletal diseases. We constantly develop new models and improve existing models for oncology and skeletal diseases as part of our strategy. Within oncology, we concentrate on orthotopic and metastasis models. Particularly in cancers that develop bone metastases like breast, prostate, lung cancer, and multiple myeloma. We also have various R&D activities in immuno-oncology, such as establishing disease models with humanized mouse models and immune cell killing assays in vitro. In the field of skeletal disease, our focus is in rare bone diseases, bone safety and versatile bone cell cultures.
The NK-ENGAGE project
Pharmatest Services is part of the ongoing NK-ENGAGE project (Novel Synthetic Polypeptides for Natural Killer Cell -mediated Immunotherapy for the Treatment of Multiple Myeloma). Project has been qualified as a Eurostars program and is driven by a Nordic research consortium including institutes and companies from Sweden, Norway and Finland. This Eurostars R&D project focuses on developing and providing preclinical proof of concept for a novel synthetic small polypeptide for NK cell-based immunotherapy as treatment of MM, which will be validated in novel preclinical models established by Pharmatest and Oslo University Hospital.
The NK-ENGAGE research consortium comprises of esteemed institutions and well-known biotech companies including Oncopeptides, Sweden and their collaborator the Royal Institute of Technology in Stockholm, Oslo University Hospital, Norway, and Pharmatest Services, Finland.
Pharmatest has also participated in the following national and EU-projects in previous years:
NanOrganoid consortium (the Academy of Finland funded consortium)
ACT project (in Eurostars program)
HUMiC project (in EuroTransBio program)
D-SIST project (as coordinator, in Eurostars program)
PORAC project (in Eurostars program)
ERIC project (in EuroTransBio program)
DISC-SCREEN project (in Eurostars program)
Headquarters, Research laboratories
Pharmatest Services Itäinen Pitkäkatu 4 A, 5th floor 20520 Turku FINLAND
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.